glycyrrhizic acid has been researched along with Adenocarcinoma of Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gowda, P; Joshi, SD; Kumawat, RK; Patrick, S; Sen, E | 1 |
1 other study(ies) available for glycyrrhizic acid and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Repurposing Methotrexate in Dampening SARS-CoV2-S1-Mediated IL6 Expression: Lessons Learnt from Lung Cancer.
Topics: A549 Cells; Adenocarcinoma of Lung; Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Cell Line, Tumor; COVID-19; COVID-19 Drug Treatment; Cytokine Receptor gp130; Folate Receptor 2; Glycyrrhizic Acid; HMGB1 Protein; Humans; Immunosuppressive Agents; Interleukin-6; Janus Kinase 1; Lung Neoplasms; Methotrexate; Phosphorylation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; STAT3 Transcription Factor | 2022 |